Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Embecta Corp. (EMBC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
28.79-0.62 (-2.11%)
At close: 04:00PM EDT
28.79 0.00 (0.00%)
After hours: 04:49PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close29.41
Open29.38
Bid11.59 x 900
Ask28.91 x 800
Day's Range28.79 - 30.39
52 Week Range23.62 - 49.00
Volume301,696
Avg. Volume406,828
Market Cap1.665B
Beta (5Y Monthly)N/A
PE Ratio (TTM)5.03
EPS (TTM)5.72
Earnings DateAug 15, 2022
Forward Dividend & Yield0.60 (2.08%)
Ex-Dividend DateAug 25, 2022
1y Target Est30.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
12% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for EMBC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Embecta Corp.
    EMBC: Lowering target price to $31.00EMBECTA CORP has an Investment Rating of HOLD; a target price of $31.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • Investopedia

    Top Pharmaceutical Stocks for Q4 2022

    These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q4 2022.

  • InvestorPlace

    3 Hidden Gem Stock Picks to Beat the September Market Slump

    These days the most popular stocks to follow are either meme plays or the most blue-chip S&P 500 companies. Very few investors seem to be interested in hidden gem stock picks. About halfway through September, the index is down almost 15% year-to-date. Of the 11 sectors in the index, only energy (up 44.8%) and utilities (up 7.5%) are up for the year. Of the 503 stocks in the index, 318 are down for the year. One possibility for finding hidden gem stock picks to beat the September slump is to limi

  • GlobeNewswire

    embecta to Participate in Upcoming Investor Conferences in September

    PARSIPPANY, N.J., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in the following upcoming investor conferences: The 2022 Wells Fargo Healthcare Conference at the Encore Boston Harbor Hotel in Boston, Mass. Management will participate in a fireside chat on Thursday, September 8 at 8:00 a.m. Eastern Time. The 20th Annual Global Healthcare Conference at the Sheraton New York, N.Y. Management will participate in a fireside c

Advertisement
Advertisement